🇮🇳 KISUNLA in India

KISUNLA (DONANEMAB-AZBT) regulatory status in India.

Marketing authorisation

CDSCO

  • Status: likely_approved

KISUNLA in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Other approved in India

Frequently asked questions

Is KISUNLA approved in India?

Yes. CDSCO has authorised it.

Who is the marketing authorisation holder for KISUNLA in India?

ELI LILLY CO is the originator. The local marketing authorisation holder may differ — check the official source linked above.